These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9618560)

  • 21. Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
    Shyng S; Ferrigni T; Nichols CG
    J Gen Physiol; 1997 Dec; 110(6):643-54. PubMed ID: 9382893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
    Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
    J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octameric stoichiometry of the KATP channel complex.
    Shyng S; Nichols CG
    J Gen Physiol; 1997 Dec; 110(6):655-64. PubMed ID: 9382894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
    Tammaro P; Ashcroft FM
    J Physiol; 2007 Nov; 584(Pt 3):743-53. PubMed ID: 17855752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
    Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
    EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y
    Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
    Ueda K; Inagaki N; Seino S
    J Biol Chem; 1997 Sep; 272(37):22983-6. PubMed ID: 9287292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
    Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
    Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP-sensitive K+ channels: regulation of bursting by the sulphonylurea receptor, PIP2 and regions of Kir6.2.
    Ribalet B; John SA; Xie LH; Weiss JN
    J Physiol; 2006 Mar; 571(Pt 2):303-17. PubMed ID: 16373383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
    Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
    J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of KATP channel inhibition by ATP.
    Tucker SJ; Gribble FM; Proks P; Trapp S; Ryder TJ; Haug T; Reimann F; Ashcroft FM
    EMBO J; 1998 Jun; 17(12):3290-6. PubMed ID: 9628866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies.
    Seino S
    Annu Rev Physiol; 1999; 61():337-62. PubMed ID: 10099692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A touching case of channel regulation: the ATP-sensitive K+ channel.
    Tucker SJ; Ashcroft FM
    Curr Opin Neurobiol; 1998 Jun; 8(3):316-20. PubMed ID: 9687347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits.
    Trapp S; Tucker SJ; Ashcroft FM
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8872-7. PubMed ID: 9238070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel activation by isoflurane in a heterologous expression system.
    Bienengraeber M; Warltier DC; Bosnjak ZJ; Stadnicka A
    Anesthesiology; 2006 Sep; 105(3):534-40. PubMed ID: 16931986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.